在临床试验和临床实践环境中对银屑病临床严重程度的实际评估：来自GRAPPA 2016年会的报告

Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.

作者信息

Merola Joseph F, Gottlieb Alice B

机构信息

From the Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dermatology, New York Medical College, Valhalla, New York, USA.

J.F. Merola, MD, MMSc, Assistant Professor, Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School; A.B. Gottlieb, MD, PhD, Professor of Dermatology, New York Medical College.

出版信息

J Rheumatol. 2017 May;44(5):691-692. doi: 10.3899/jrheum.170147.

DOI:10.3899/jrheum.170147

PMID:28461528

Abstract

At the 2016 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we presented the case for quantitatively assessing the extent of both psoriasis and psoriatic arthritis in the clinical setting, with a particular focus on the validation and expanded novel use of the PGAxBSA (static physician's global assessment × body surface area of involvement) in the era of targeted metrics. Herein, we summarize our presentation.

摘要

在2016年银屑病和银屑病关节炎研究与评估小组（GRAPPA）年会上，我们提出了在临床环境中对银屑病和银屑病关节炎的程度进行定量评估的理由，特别关注在有针对性指标时代PGAxBSA（静态医生整体评估×受累体表面积）的验证及扩展新用途。在此，我们总结我们的发言内容。